Research
Mixed
Combining GLP-1 receptor agonists with resistance training and/or specific nutritional strategies (e.g., higher protein, ketogenic therapy) preserves fat-free mass and muscle strength better than pharmacotherapy alone.
To prevent muscle loss while on GLP-1s, consider combining your medication with resistance training and a diet that supports muscle retention, such as one higher in protein or potentially ketogenic, under medical supervision.
GoodSupportsHIGH confidence
However, when tirzepatide was combined with low-energy ketogenic therapy, it was found to preserve fat-free mass, muscle strength, and resting metabolic rate for at least 12 weeks.
Why this rating
Supported by specific clinical trials and meta-analyses cited.
Source
Saving muscle while losing weight: A vital strategy for sustainable results while on glucagon-like peptide-1 related drugs
Maja Cigrovski Berković et al. · World Journal of Diabetes · 2025
DOI 10.4239/wjd.v16.i9.109123
narrative_reviewCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- GLP-1 receptor agonists (semaglutide, tirzepatide, retatrutide) cause significant loss of lean muscle mass (up to 40% of total weight loss), which contributes to reduced resting energy expenditure and increased risk of sarcopenia and weight regain.Good
- Myostatin and activin A inhibitors (e.g., bimagrumab, trevogrumab, garetosmab) combined with GLP-1 agonists can increase lean mass and reduce fat mass more effectively than GLP-1 agonists alone.Moderate
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →